Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers
- 463 Downloads
The effect of piperine on the bioavailability and pharmacokinetics of propranolol and theophylline has been examined in a crossover study. Six subjects in each group received a single oral dose of propranolol 40 mg or theophylline (150 mg) alone or in combination with piperine 20 mg daily for 7 days. An earlier tmax and a higher Cmax and AUC were observed in the subjects who received piperine and propranolol. It produced a higher Cmax, longer elimination half-life and a higher AUC with theophylline.
In clinical practice, the enhanced systemic availability of oral propranolol and theophylline could be exploited to achieve better therapeutic control and improved patient compliance.
Key wordsPiperine Propranolol Theophylline pharmacokinetics drug interaction
Unable to display preview. Download preview PDF.
- 1.Atal CK, Zutshi U, Rao PG (1981) Scientific evidence on the role of Ayurvedic herbals on bioavailability of drugs. J Ethnopharmacol 4: 229–232Google Scholar
- 2.Zutshi RK, Singh R, Zutshi U, Johri RK, Atal CK (1985) Influence of piperine on rifampicin blood levels in patients of pulmonary tuberculosis. J Assoc Physicians India 33: 223–226Google Scholar
- 3.Bano G, Amla V, Raina RK, Johri RK, Zutshi U, Chopra CL (1987) The effect of piperine on kinetics of phenytoin in healthy volunteers. Planta Medica 53: 568–569Google Scholar
- 4.Shand DG, Nuckoll EN, Gates JA (1970) Plasma propranolol levels in adults with observation in four children. Clin Pharmacol Ther 11: 112–120Google Scholar
- 5.Bano G, Raina RK, Sharma DB (1986) Pharmacokinetics of carbamazepine in protein energy malnutrition. Pharmacology 32: 232–236Google Scholar
- 6.Shargel L, Yu ABC (1980) Review of mathematical fundamentals. In: Applied biopharmaceutics and pharmacokinetics Appleton Century Crofts, New York, pp 1–12Google Scholar
- 7.Gibaldi M (1984) Introduction to pharmacokinetics Biopharmaceutics and Clinical pharmacokinetics. Philadelphia, Lea and Febiger, Philadelphia, pp 1–16Google Scholar
- 8.Atal CK, Dubey RK, Singh J (1985) Biochemical basis of enhanced drug bioavailability by piperine: Evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther 232: 258–262Google Scholar
- 9.Leahey WJ, Neill JD, Varma MP, Shanks RG (1980) Comparison of the efficacy and pharmacokinetics of conventional propranolol and a long acting preparation of propranolol. Br J Clin Pharmacol 9: 33–40Google Scholar
- 10.Piyachaturawat P, Glinsukon T, Toskulkao C (1983) Acute and Subacute toxicity of piperine in mice, rats and hamsters. Toxicol Lett 16: 351–359Google Scholar